Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole plasma protein binding in specific patient subsets
2013-000559-42Phase 4Terminated
- Sponsor
- UZ Leuven
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in invasive mycoses and mycoses, sponsored by UZ Leuven. Primary endpoint: Protein binding characteristics of voriconazole in human plasma. Started Feb 2013; status: terminated.
02
Drugs
voriconazole
03
Conditions
invasive mycosesmycoses
Beyond the preview
Go deeper on 2013-000559-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000559-42.